News Zoryve Cream Now Available for Plaque Psoriasis By Brian Park, PharmD Publish Date August 10, 2022
Safety Alerts and Recalls Companies Selling Unapproved Drugs for Mole, Skin Tag Removal Get FDA Warning Letter By Brian Park, PharmD Publish Date August 10, 2022
News Juvéderm Volux XC Approved for Improving Jawline Definition By Brian Park, PharmD Publish Date August 3, 2022
Drugs in the Pipeline FDA to Review Resubmitted Application for Severe Burn Therapy NexoBrid By Brian Park, PharmD Publish Date August 3, 2022
Drugs in the Pipeline Study Investigating Oral JAK Inhibitor for Alopecia Areata Meets Endpoint By Brian Park, PharmD Publish Date August 1, 2022
News Opzelura Cream Approved for Nonsegmental Vitiligo By Brian Park, PharmD Publish Date July 19, 2022
Drugs in the Pipeline Vilobelimab Fast Tracked for Ulcerative Pyoderma Gangrenosum By Brian Park, PharmD Publish Date July 6, 2022
News Dupixent Approved for Atopic Dermatitis in Younger Pediatric Patients By Brian Park, PharmD Publish Date June 8, 2022
Drugs in the Pipeline Improvements in Skin Clearance Maintained With Lebrikizumab in Atopic Dermatitis Trials By Brian Park, PharmD Publish Date June 8, 2022
Drugs in the Pipeline Roflumilast Foam Looks Promising in Seborrheic Dermatitis Trial By Brian Park, PharmD Publish Date June 6, 2022
News Lotion, Cream, Gel, and Ointment Similarly Effective for Childhood Eczema Publish Date June 6, 2022